制剂
Formulation
| No. |
Product Name |
Standard |
Strength |
| 1 |
Chlorpromazine injection |
JP/USP/BP |
25mg/1ml, 50mg/2ml |
| 2 |
Fosfomycin trometamol sachet |
EP |
2g, 3g |
| 3 |
Prednisolone acetate ophthalmic suspension |
USP |
1% |
| 4 |
Troxerutin tablet |
Enterprise Standard |
60mg |
| 5 |
Ciprofloxacin hydrochloride tablet |
BP/USP |
250mg |
| 6 |
Flunarizine Dihydrochloride Capsule |
Enterprise Standard |
5mg |
| 7 |
Gastro-resistant Omeprazole Capsules |
BP/CP |
20mg |
| 8 |
Amoxicillin Capsule |
JP/USP/BP |
250mg，500mg |
| 9 |
Captopril tablet |
BP/USP |
25mg |
| 10 |
Acyclovir tablet |
BP/USP |
100mg |
| 11 |
Levofloxacin Hydrochloride tablet |
Enterprise Standard |
100mg |
| 12 |
Simvastatin tablet |
BP/USP |
10mg |
| 13 |
Ciprofloxacin hydrochloride tablet |
BP/USP |
250mg |
The above-mentioned products are produced or sold only in countries or regions where the relevant patents have expired in areas without patent protection.
